Chronic pain (neuropathic pain, inflammatory pain, cancer pain) is a major health problem. Opiate-based drugs, such as morphine and morphine derivatives, are the primary standard of care for the treatment of chronic pain.  Unfortunately, patients develop tolerance to opiates due to desensitization of the opiate receptor.  Thus, alternative anti-nociceptive ("pain killing") pathways need to be explored for treatment of chronic pain. The N-type voltage-gated Ca2+ channels (CaV2.2s) in dorsal root ganglia neurons is a well validated target for chronic pain (1, 2). We previously demonstrated the interaction between CaV2.2 and the first PDZ domain of molecular adaptor protein Mint1 (3). In additional experiments we demonstrated that carboxyl-terminal association of CaV2.2 protein with the Mint1-PDZ domain plays an important role in synaptic targeting and function of N-type Ca2+ channels (4). The following describes a homogeneous time-resolved fluorescence resonance energy transfer (HTRF) HTS assay to identify small molecule inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide (NC peptide). Compounds that disrupt the interaction would result in decrease of TR-FRET ratio and are detected in the assay. Small molecules identified in the screening would serve as useful probes for studies of synaptic function of N-type Ca2+ channels, its validation as a therapeutic target and/or as starting point for development of anti-nociceptive therapeutic agents with novel mechanism of action. Assay materials: 1) Biotin, glutathione S-transferase (GST)-fusion protein (GST-M15) and biotinylated (biotin-) N-type Ca2+ channel carboxyl-terminal peptide (biotin-NC peptide) corresponding to the carboxyl-terminal tail of CaV2.2 protein were supplied by assay provider. 2) Anti-GST monoclonal antibody labeled with europium cryptate (EuK-anti-GST-mAb (CisBio cat# 61GSTKLB) and streptavidin-XL665 (CisBio cat# 610SAXLB ). 3) Potassium Fluoride (KF)  (Aqua Solutions cat# P3901) 4) Tween-20 (Sigma cat# 9416) 5) Bovine Serum Albumin (Sigma cat# A7888) Working solutions: 1. Assay buffer: 25 mM HEPES, pH 7.2, 100mM NaCl,0.1% BSA, 0.005% Tween-20 2. Mint1-PDZ working solution (1.75X final concentration) contains 3.5 nM GST-MINT-PDZ and 0.63 nM EuK-anti-GST-mAb 3. Biotin-NC peptide-XL665 solution (3.5X final concentration) contained 167 nM biotin-NC peptide and 46.6 nM streptavidin XL665. 4. Biotin solution (3.5X final concentration): 167 nM Biotin 3.5X final concentration) and 46.6 nM streptavidin XL665. 5. TR-FRET enhancing solution (7X final concentration): 3.2 M KF. Primary Screen and Single-concentration confirmation 1) Dispense 4 uL Mint1-PDZ working solution to entire 1536-well white plate (Corning# 3725) 2) Using a HighRes biosolution pintool equipped with V&P Scientific pins add 70 nL of DMSO (col 1-4) or 2-mM compound solutions in DMSO (col 5-48) 3) Incubate for 30 mins 4) Dispense 2 uL Biotin working solution to columns 1 & 2 5) Dispense 2 uL of Biotin-NC peptide working solutions to columns 3-48 6) Incubate for 30 mins 7) Dispense 1 uL 3.2 M KF to entire plate 8) Spin down plates at 1000 rpm for 1 min in an Eppendorf 5810 centrifuge. 9) Read plate on a BMG Labtech PheraStar in a Homogeneous Time-Resolved Fluorescence mode (Ex: 337 nm; Em: 620/665 nm) within 10 min
bao:BAO_0001067 "2073_2" ; # "is primary assay of" -> "2073_2"
bao:BAO_0001067 "2091" ; # "is primary assay of" -> "2091"
bao:BAO_0000812 "2093" ; # "has summary assay" -> "2093"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000223 ; # "has assay format" -> "protein complex format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000280 ; # "has participant" -> "ion channel"
bao:BA0_0090012 bao:BAO_0000365 ; # "has participant" -> "cytosolic protein" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_00020101 ; # "is bioassay type of" -> "protein-protein interaction assay"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "biotin-NC peptide/GST-MINT-PDZ" ; # "protein-protein" -> "biotin-NC peptide/GST-MINT-PDZ"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000207 bao:BAO_0000004 ; # "has detection method" -> "time resolved fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "To identify small molecule inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide" ; # "screening campaign name" -> "To identify small molecule inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide"
bao:BAO_0002853 "Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay" ; # "has assay title" -> "Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay"
bao:BAO_0003105 <http://purl.obolibrary.org/obo/GO_0005488> ; # "has function" -> "binding"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0002833 "30 minute" ; # "has incubation time value" -> "30 minute"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Ilya Bezprozvanny" ; # "material entity assay provider" -> "Ilya Bezprozvanny" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000693 ; # "has participant" -> "HEPES" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0001038 ; # "has participant" -> "Tween 20" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BA0_0090012 "Voltage-dependent N-type calcium channel subunit alpha-1B" ; # "has participant" -> "Voltage-dependent N-type calcium channel subunit alpha-1B"
bao:BA0_0090012 "Amyloid beta A4 precursor protein-binding family A member 1" ; # "has participant" -> "Amyloid beta A4 precursor protein-binding family A member 1"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_10116> ; # "has organism" -> "Rattus norvegicus"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Q00975" ; # "uniprot ID" -> "Q00975"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "O35430" ; # "uniprot ID" -> "O35430"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10116" ; # "NCBI taxonomy ID" -> "10116"
bao:BAO_0002662 bao:BAO_0000644 ; # "has quality" -> "truncated"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BAO_0002622 bao:BAO_00020127 ; # "has purity value" -> "purified"
bao:BAO_0000502 "\"Anti-GST monoclonal antibody labeled with europium cryptate, EuK-anti-GST-mAb, Cisbio cat 61GSTKLB\"" ; # "antibody" -> ""Anti-GST monoclonal antibody labeled with europium cryptate, EuK-anti-GST-mAb, Cisbio cat 61GSTKLB""
bao:BA0_0090012 "EuK" ; # "has participant" -> "EuK"
bao:BA0_0090012 "XL665" ; # "has participant" -> "XL665"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000705 ; # "uses detection instrument" -> "PHERAstar Plus"
bao:BAO_0000737 bao:BAO_0000863 ; # "has manufacturer" -> "BMG Labtech" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "337 nanometer" ; # "has excitation wavelength value" -> "337 nanometer"
bao:BAO_0002918 "620 nanometer" ; # "has emission wavelength value" -> "620 nanometer"
bao:BAO_0002918 "665 nanometer" ; # "has emission wavelength value" -> "665 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "5" ; # "PubChem TID" -> "5"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "20" ; # "has concentration value" -> "20"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie" ; # "Annotated by" -> "kunie"
bao:BAO_0000540 "2073_1" ; # "is confirmatory assay of" -> "2073_1"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
